Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants.
Federico Martinón-Torres, Hanna Czajka, Kimberly J. Center, Jacek Wysocki, Ewa Majda-Stanislawska, Felix Omeñaca, Enrique Bernaola Iturbe, Daniel Blazquez Gamero, Ana Concheiro-Guisán, Francisco Gimenez-Sanchez, Leszek Szenborn, Peter C. Giardina, Scott Patterson, William C. Gruber, Daniel A. Scott, Alejandra Gurtman
Journal:
Pediatrics
Publicación independiente
Impact factor
5.359
Q1
Vaccine evaluation: lessons from a meningococcal B vaccine.
Sarfatti A, Martinón-Torres F, Nadel S
Journal:
Arch Dis Child
Publicación independiente
Impact factor
3.041
Q1
Should the Indication of Pneumococcal Polysaccharide Vaccine in Children Be Definitively Withdrawn?
Federico Martinón Torres
Journal:
Clin Infect Dis
Publicación independiente
Impact factor
8.313
Q1
Rotavirus vaccination in Europe: drivers and barriers.
N Parez, C Giaquinto, C Du Roure, F Martinon-Torres, V Spoulou, P Van Damme, T Vesikari
Journal:
Lancet Infect Dis
Publicación independiente
Impact factor
24.446
Q1
RSV—Still More Questions Than Answers
Louis Bont, Eugenio Baraldi, Brigitte Fauroux, Anne Greenough, Terho Heikkinen, Paolo Manzoni, Federico Martinón-Torres, Harish Nair and Nikolaos G. Papadopoulos, on behalf of ReSViNET
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q2
Prognostic markers of meningococcal disease in children: recent advances and future challenges.
María Montero-Martín, David P Inwald, Enitan D Carrol & Federico Martinón-Torres
Journal:
Expert Rev Infect Ther
Publicación independiente
Impact factor
3.767
Q1
Pneumococcal Vaccination in Europe: Schedule Adherence
Alain Gervaix; Filippo Ansaldi; Antonio Brito-Avô; Chiara Azzari, Markus Knuf; Federico Martinón-Torres; David Tuerlinckx; Myint TinTin Htar, and George A. Syrogiannopoulos
Journal:
Clin Therap
Publicación independiente
Impact factor
3.119
Q2
Overuse of bronchodilators and steroids in bronchiolitis of different severity Bronchiolitis-study of variability, appropriateness, and adequacy
C. Ochoa Sangrador, J. González de Dios, Research Group of the aBREVIADo Project
Journal:
Allergol Immunopathol (Madr)
Publicación independiente
Impact factor
1.276
Q3
Year:
2014
Doi:
Caracterización microbiológica de las gastroenteritis agudas virales atendidas en un servicio de pediatría en un área de alta cobertura vacunal frente a rotavirus
Carlos García-Magán, María José de Castro-López, José Llovo-Taboada, Carmen Curros-Novo, Miriam Puente-Puig, Alicia Sánchez-Fauquier, Federico Martinón-Torres
Journal:
Enferm Infecc Microbiol Clin
Publicación independiente
Impact factor
1.654
Q3
Evolving Role of 13-valent Pneumococcal Conjugate Vaccine in Clinical Practice
Azzari C, Martinón-Torres F, Schmitt HJ, Dagan R.
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q2
Evaluating the accuracy of AIM panels at quantifying genome ancestry
Jacobo Pardo-Seco, Federico Martinón-Torres and Antonio Salas
Journal:
BMC Genomics
Publicación independiente
Impact factor
3.594
Q2
Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome
Jan De Waele, Jeffrey Lipman, Yasser Sakr, John C Marshall, Philippe Vanhems, Casiano Barrera Groba, Marc Leone, Jean-Louis Vincent and for the EPIC II Investigators
Journal:
BMC Infec Dis
Publicación independiente
Impact factor
2.688
Q3
Year:
2014
Doi:
Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study
Thierry Gustot, Peter Felleiter, Peter Pickkers, Yasser Sakr, Jordi Rello, Dimitrios Velissaris, Charalampos Pierrakos, Fabio S. Taccone, Pavel Sevcik, Christophe Moreno, Jean-Louis Vincent and for the EPIC II Group of Investigators
Journal:
Liver Internat.
Publicación independiente
Impact factor
5.175
Q1
Year:
2014
Doi:
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants.
Federico Martinon-Torres, Francisco Gimenez-Sanchez, Enrique Bernaola-Iturbe,Javier Diez-Domingo, Qin Jiang, John L. Perez
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Fe de errores de «Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes»
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinon-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel, J.A. Vázquez
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
A Genome-Wide Study of Modern-Day Tuscans: Revisiting Herodotus’s Theory on the Origin of the Etruscans
Jacobo Pardo-Seco, Alberto Gómez-Carballa, Jorge Amigo, Federico Martinón-Torres, Antonio Salas
Journal:
PLoS ONE
Publicación independiente
Impact factor
2.740
Q2
Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinon-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel, J.A. Vázquez
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
Immunisation against meningococcus B: the case of Spain
Federico Martinón Torres
Journal:
Lancet
Publicación independiente
Impact factor
60.392
Q1
Read my lips: oral manifestations of systemic diseases.
de Castro López MJ, Illade Quinteiro L, Martinón Torres F, Cutrín Prieto JM.
Journal:
Journal of Pediatrics
Publicación independiente
Impact factor
3.700
Q1
Dr. Google: what about the human papillomavirus vaccine?
Leticia Pías-Peleteiro, Javier Cortés-Bordoy, and Federico Martinón-Torres
Journal:
Human Vaccines & Immunother
Publicación independiente
Impact factor
2.619
Q2
Adaptive support ventilation: State of the art review.
Fernández J, Miguelena D, Mulett H, Godoy J, Martinón-Torres F.
Journal:
Indian J Crit Care Med
Publicación independiente
Impact factor
Indian Signatures in the Westernmost Edge of the European Romani Diaspora: New Insight from Mitogenomes
Alberto Gómez-Carballa, Jacobo Pardo-Seco, Laura Fachal, Ana Vega, Miriam Cebey, Nazareth Martinón-Torres, Federico Martinón-Torres, Antonio Salas
Journal:
PLoS ONE
Publicación independiente
Impact factor
2.740
Q2
Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes.
Jethro A. Herberg, Myrsini Kaforou, Stuart Gormley, Edward R. Sumner, Sanjay Patel, Kelsey D. J. Jones, Stéphane Paulus, Colin Fink, Federico Martinon-Torres, Giovanni Montana, Victoria J. Wright, and Michael Levin
Journal:
J. Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule
Gail L. Rodgersa, Susanna Esposito, Nicola Principi, Maricruz Gutierrez-Brito, Javier Diez-Domingo, Andrew J. Pollard, Matthew D. Snape,Federico Martinón-Torres, William C. Gruber, Scott Patterson, Allison Thompson,Alejandra Gurtman, Peter Paradiso, Daniel A. Scott
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
No results found.
Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial
Martinón-Torres F, Safadi MAP, Martinez AC, Marquez PI, Torres JCT, Weckx LY, Moreira ED Junior, Mensi I, Calabresi M, Toneatto D
Doi:
Vaccine
Factor de impacto:
Q2
Doi:
Phylogenetic and population-based approaches to mitogenome variation do not support association with male infertility.
Gómez-Carballa A, Pardo-Seco J, Martinón-Torres F, Salas A
Doi:
J Hum Gene
Factor de impacto:
Q2
Doi:
Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial
Marshall HS, Richmond PC, Beeslaar J, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Lee SS, Perez JL; 6108A12001 Study Investigators.
Doi:
Lancet Infect Dis
Factor de impacto:
Q1
Doi:
Circulating Antibody 1 and 2 Years After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Preterm Compared With Term Infants
F. Martinón-Torres, J. Wysocki, K. J. Center, H. Czajka, E. Majda-Stanislawska, F. Omeñaca, A. Concheiro-Guisan, F. Gimenez-Sanchez, L. Szenborn, D. Blázquez-Gamero, L. Moreno-Galarraga, P. C. Giardina, G. Sun, W. C. Gruber, D. A. Scott and A. Gurtman
Doi:
Pediatr Infect Dis J
Factor de impacto:
Q2
Doi:
ISL1 is a major susceptibility gene for classic bladder exstrophy and a regulator of urinary tract development
Zhang R, Knapp M, Suzuki K, Kajioka D, Schmidt JM, Winkler J, Yilmaz O, Pleschka M, Cao J, Clementson Kockum C, Barker G, Holmdahl G, Beaman G, Keene D, Woolf AS, Cervellione RM, Wei Cheng, Wilkins S, Gearhart JP, Sirchia F, Di Grazia M, Ebert AK, Rösch W, Ellinger J, Jenetzky E, Zwink N, Feitz WF, Marcelis C, Schumacher J, Martinón-Torres F, Lloyd Hibberd M,Chuen Khor C, Heilmann-Heimbach S, Barth S, Boyadjiev SA, Brusco A, Ludwig M, Newman W, Nordenskjöld A, YamadaG, Odermatt B, Reutter H
Doi:
Scientific Reports
Factor de impacto:
Q1
Doi:
Otra lección británica sobre vacunas frente al meningococo
Federico Martinón Torres
Doi:
Evid. Pediatr
Factor de impacto:
Doi:
Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial
Marco Aurelio P. Safadi, Federico Martinon-Torres, Lily Yin Weckx, Edson Duarte Moreira Junior, Eduardo Jorge da Fonseca Lima, Ilhem Mensi, Marco Calabresi, Daniela Toneatto
Doi:
Vaccine
Factor de impacto:
Q2
Doi:
International Survey of Critically Ill Children With Acute Neurologic Insults: The Prevalence of Acute Critical Neurological Disease in Children: A Global Epidemiological Assessment Study
Ericka L. Fink, Patrick M. Kochanek, Robert C. Tasker, John Beca, Michael J. Bell, Robert S. B. Clark, Jamie Hutchison, Monica S. Vavilala, Anthony Fabio, Derek C. Angus, R. Scott Watson, on behalf of the Prevalence of Acute critical Neurological Disease in Children: A Global Epidemiological Assessment (PANGEA) Investigators, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, and Pediatric Neurocritical Care Research Group (PNCRG) (Smith C, Ryan C, Koch J, Walson K, Truemper E, Flori H, Simon J, Exo J, Markovitz B, Morzov R, LaRovere K, Nishisaki A, Prodell J, Sisko M, McGowan S, Idell T, Twelves C, Kamens W, Park B, Diliberto MA, Fink E, Abraham A, Hanson S, Murkowski K, Nowak J, Zielinski E, Overman A, Tieves K, Williams T, Hughes-Schalk A, Dean N, Bala A, Watson A, Wheeler D, Banschbach S, Beckman E, Frank E, Nett S, Jarvis JD, Higgerson R, Christie L, Reed J, Cheifetz I, Tate S, Uhl T, Haskins-Kiefer C, Hendricks P, Green J, Barron-Nelson R, Baisch S, Evenson J, Wendorf H, McKinley D, Sankey J, Bembea M, Noje C, White E, O'Brien N, Maa T, Zink M, Weidner B, Biagas K, Superville M, Traube C, Carlo C, Thomas N, Spear D, Buttram S, Franken A, Bennett T, Kim EH, Nitu M, Rider C, Vavilala MS, Lum D, Parker M, Culver K, Loftis L, Jaimon N, Shellington D, Foley J, Irazuzta J, Alleyne T, Bateman S, Sylvia M, Cholette JM, Willson D, Kelly R, Pineda J, Hicks T, Middleton D, Day T, Li S, Kandil S, Giuliano J, Skippen P, Wensley D, Krahn G, Bourdages M, Dugas MA, Gosselin L, Santschi M, Fraser D, Blom C, Jouvet P, Poitras N, Bertout L, Dumitrascu M, Gottesman R, Trudel K, Hutchison J, Kandath S, Van Huyse J, Fusco K, Niera P, Iolster T, Barbosa M, Soares V, Lima F, Betanzo RB, Fernández Laverde M, Becerra R, Guilbert J, Léger PL, Ringuier B, Brissaud O, Payen V, Milesi C, Liet JM, Legrande A, Breining A, Bienz J, Javouhey E, Ginhoux T, Courtil-Teyssedre S, Bergounioux J, Sachs P, Leclerc F, Lampin ME, Amigoni A, Marzollo A, Barzdina A, Tibboel D, Geleijns K, van Gestel S, Dinis A, García-Iñiguez J, Madurga-Revilla P, Martinon-Torres F, De Castro MJ, Lopez-Herce J, Urbano J, García-Soler P, Fernandez-Carrion F, Rossich R, Arjona D, Borrego R, Karam O, Dursun O, Tekguc H, Kendirli T, Odek C, Yaman A, Arslankoylu A, Tume L, Scholefield B, Winmill H, Morley S, White D, Mukhtyar B, Agbeko R, Peters M, Jones A, Inwald D, Brewer A, Abdulla A, Deep A, Nsirim E, Shefler A, Joshi R, Muhuntha G, Hudnott P, MacDonald M, Pappachan J, Gray MP, Rushforth K, Abdelmogheth AA, Mohamed AF, Dhande NR, Abdulrahim RA, Saleh S, Al-Hasani S, Argent A, Salie S, Ranjit S, Jayakumar I, Kamath S, P AV, Cheung HM, Wang Y, Festa M, Walker K, Watts N, Erickson S, Slater A, Long D, Butt W, Delzoppo C, Yung M, Ganu S, Letton G, Sherring C, Rea M, Bushell T)
Doi:
Pediatric Critical Care Med
Factor de impacto:
Q1
Doi:
Salivary epidermal growth factor correlates with hospitalization length in rotavirus infection
J. Gómez-Rial, M. J. Curras-Tuala, C. Talavero-González, C. Rodríguez-Tenreiro, L. Vilanova-Trillo, A. Gómez-Carballa, I. Rivero-Calle, A. Justicia-Grande, J. Pardo-Seco, L. Redondo-Collazo, A. Salas and F. Martinón-Torres
Doi:
BMC Infec Dis
Factor de impacto:
Q3
Doi:
Safety, Tolerability and Immunogenicity of Pentavalent Rotavirus Vaccine Manufactured by a Modified Process
Federico Martinón-Torres, David Greenberg, Meera Varman, John A. Killar, Darcy Hille, Erica L. Strable, Jon E. Stek, and Susan S. Kaplan,
Doi:
Pediatr Infect Dis J.
Factor de impacto:
Q2
Doi:
SIMULTANEOUS VIRAL WHOLE-GENOME SEQUENCING AND DIFFERENTIAL EXPRESSION PROFILING IN RESPIRATORY SYNCYTIAL VIRUS INFECTION OF INFANTS
Gu-Lung Lin, Tanya Golubchik, Simon Drysdale, Daniel O’Connor, Kimberley Jefferies, Anthony Brown, Mariateresa de Cesare, David Bonsall, M. Azim Ansari, Jeroen Aerssens, Louis Bont, Peter Openshaw, Federico Martinón-Torres, Rory Bowden, and Andrew J. Pollard; the RESCEU Investigators
The Journal of Infectious Diseases
Factor de impacto:
Q1
Doi:
IDENTIFICATION OF NOVEL RISK LOCI AND CAUSAL INSIGHTS FOR SPORADIC CREUTZFELDT-JAKOB DISEASE: A GENOME-WIDE ASSOCIATION STUDY
Emma Jones, Holger Hummerich, Emmanuelle Viré, James Uphill, Athanasios Dimitriadis, Helen Speedy, Tracy Campbell, Penny Norsworthy, Liam Quinn, Jerome Whitfield, Jacqueline Linehan, Zane Jaunmuktane, Sebastian Brandner, Parmjit Jat, Akin Nihat, Tze How Mok, Parvin Ahmed, Steven Collins, Christiane Stehmann, Shannon Sarros, Gabor G Kovacs, Michael D Geschwind, Aili Golubjatnikov, Karl Frontzek, Herbert Budka, Adriano Aguzzi, Hata Karamujić-Čomić, Sven J van der Lee, Carla A Ibrahim-Verbaas, Cornelia M Van Duijn, Beata Sikorska, Ewa Golanska, Pawel Liberski, Miguel Calero, Olga Calero, Pascual Sanchez-Juan, Antonio Salas, Federico Martinón-Torres, Elodie Bouaziz-Amar, Stephane Haik, Jean-Louis Laplanche, Jean-Phillipe Brandel, Phillipe Amouyel, Jean-Charles Lambert, Piero Parchi, Anna Bartoletti-Stella, Sabina Capellari, Anna Poleggi, Anna Ladogana, Maurizio Pocchiari, Serena Aneli, Giuseppe Matullo, Richard Knight, Saima Zafar, Inga Zerr, Stephanie Booth, Michael B Coulthart, Gerard H Jansen, Katie Glisic, Janis Blevins, Pierluigi Gambetti, Jiri Safar, Brian Appleby, John Collinge, Simon Mead
Factor de impacto:
Doi:
SEROPREVALENCE OF SARS-COV-2 AMONG PEDIATRIC HEALTHCARE WORKERS IN SPAIN
Ana Dacosta-Urbieta, Irene Rivero-Calle, Jacobo Pardo-Seco, Lorenzo Redondo-Collazo, Antonio Salas, Jose Gómez-Rial and Federico Martinón-Torres
Factor de impacto:
Doi:
ROLE OF MONOCYTES/MACROPHAGES IN COVID-19 PATHOGENESIS: IMPLICATIONS FOR THERAPY.
Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F.
Factor de impacto:
Doi:
RESPIRATORY SYNCYTIAL VIRUS CONSORTIUM IN EUROPE (RESCEU) BIRTH COHORT STUDY: DEFINING THE BURDEN OF INFANT RESPIRATORY SYNCYTIAL VIRUS DISEASE IN EUROPE
Joanne G Wildenbeest, Roy P Zuurbier, Koos Korten, Marlies A van Houten, Marie N Billard, Nicole Derksen-Lazet, Matthew D Snape, Simon B Drysdale, Hannah Robinson, Andrew J Pollard, Terho Heikkinen, Steve Cunningham, Amanda Leach, Federico Martinón-Torres, Carmen Rodríguez-Tenreiro Sánchez, Alberto Gómez-Carballa, Louis J Bont, Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
Factor de impacto:
Doi:
PRESUMED RISK FACTORS AND BIOMARKERS FOR SEVERE RESPIRATORY SYNCYTIAL VIRUS DISEASE AND RELATED SEQUELAE: PROTOCOL FOR AN OBSERVATIONAL MULTICENTER, CASE-CONTROL STUDY FROM THE RESPIRATORY SYNCYTIAL VIRUS CONSORTIUM IN EUROPE (RESCEU)
Kimberley Jefferies, Simon B Drysdale, Hannah Robinson, Elizabeth Ann Clutterbuck, Luke Blackwell, Joseph McGinley, Gu-Lung Lin, Ushma Galal, Harish Nair, Jeroen Aerssens, Deniz Öner, Annefleur Langedijk, Louis Bont, Joanne G Wildenbeest, Federico Martinon-Torres, Carmen Rodríguez-Tenreiro Sánchez, Simon Nadel, Peter Openshaw, Ryan Thwaites, Myra Widjojoatmodjo, Linong Zhang, Thi Lien-Anh Nguyen, Carlo Giaquinto, Giuseppe Giordano, Eugenio Baraldi, Andrew J Pollard, Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
Factor de impacto:
Doi:
BIOMARKERS FOR DISEASE SEVERITY IN CHILDREN INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS: A SYSTEMATIC LITERATURE REVIEW
Öner D, Drysdale SB, McPherson C, Lin GL, Janet S, Broad J, Pollard AJ, Aerssens J; RESCEU Investigators (F Martinón-Torres)
Factor de impacto:
Doi:
BIOMARKERS FOR THE DISCRIMINATION OF ACUTE KAWASAKI DISEASE FROM INFECTIONS IN CHILDHOOD
Judith Zandstra, Annemarie van de Geer, Michael W T Tanck, Diana van Stijn-Bringas, Dimitriades, Cathelijn E M Aarts, Sanne M Dietz, Robin van Bruggen, Nina A Schweintzger, Werner Zenz, Marieke Emonts, Dace Zavadska, Marko Pokorn, Effua Usuf, Henriette A Moll, Luregn J Schlapbach, Enitan D Carrol, Stephane Paulus, Maria Tsolia, Colin Fink, Shunmay Yeung, Chisato Shimizu, Adriana Tremoulet, Rachel Galassini, Victoria J Wright, Federico Martinón-Torres, Jethro Herberg, Jane Burns, Michael Levin, Taco W Kuijpers, EUCLIDS Consortium, PERFORM Consortium and UK Kawasaki Disease Genetics Study Network
Factor de impacto:
Doi:
SINGLE-DOSE NIRSEVIMAB FOR PREVENTION OF RSV IN PRETERM INFANTS
M. Pamela Griffin, Yuan Yuan, Therese Takas, Joseph B. Domachowske, Shabir A. Madhi, Paolo Manzoni, Eric A.F. Simões, Mark T. Esser, Anis A. Khan, Filip Dubovsky, Tonya Villafana and John P. DeVincenzo for the Nirsevimab Study Group*(Federico Martinón Torres)
Factor de impacto:
Doi:
RESPIRATORY SYNCYTIAL VIRUS VACCINATION DURING PREGNANCY AND EFFECTS IN INFANTS
S.A. Madhi, F.P. Polack, P.A. Piedra, F.M. Munoz, A.A. Trenholme, E.A.F. Simões, G.K. Swamy, S. Agrawal, K. Ahmed, A. August, A.H. Baqui, A. Calvert, J. Chen, I. Cho, M.F. Cotton, C.L. Cutland, J.A. Englund, A. Fix, B. Gonik, L. Hammitt, P.T. Heath, J.N. de Jesus, C.E. Jones, A. Khalil, D.W. Kimberlin, R. Libster, C.J. Llapur, M. Lucero, G. Pérez Marc, H.S. Marshall, M.S. Masenya,F. Martinón‐Torres, J.K. Meece, T.M. Nolan, A. Osman, K.P. Perrett, J.S. Plested, P.C. Richmond, M.D. Snape, J.H. Shakib, V. Shinde, T. Stoney, D.N. Thomas, A.T. Tita, M.W. Varner, M. Vatish, K. Vrbicky, J. Wen, K. Zaman, H.J. Zar, G.M. Glenn, and L.F. Fries, for the Prepare Study Group*
Factor de impacto:
Doi: